# AbbVie Inc. (ABBV) — Q1-2023 Earnings Results

**Report date:** 2023-04-27 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2023

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 7.99%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.46 | N/A | +0.78% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No forward guidance data is available.

### What It Means

AbbVie's earnings report showed a positive surprise on EPS, but the stock reacted negatively, dropping nearly 8%. Investors may be concerned about the lack of revenue details and future guidance, which could indicate uncertainty about the company's performance going forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2023_